BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhu Q, Chen Z, Paul PK, Lu Y, Wu W, Qi J. Oral delivery of proteins and peptides: Challenges, status quo and future perspectives. Acta Pharm Sin B 2021;11:2416-48. [PMID: 34522593 DOI: 10.1016/j.apsb.2021.04.001] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Costa RODA, Passos TS, Silva EMDS, dos Santos NCS, Morais AHDA. Encapsulated Peptides and Proteins with an Effect on Satiety. Nanomaterials 2023;13:1166. [DOI: 10.3390/nano13071166] [Reference Citation Analysis]
2 Xian J, Zhong X, Huang Q, Gu H, Feng Y, Sun J, Wang D, Li J, Zhang C, Wu Y, Zhang J. N-Trimethylated chitosan coating white adipose tissue vascular-targeting oral nano-system for the enhanced anti-obesity effects of celastrol. Int J Biol Macromol 2023;236:124023. [PMID: 36924876 DOI: 10.1016/j.ijbiomac.2023.124023] [Reference Citation Analysis]
3 Zhu W, Chao Y, Jin Q, Chen L, Shen JJ, Zhu J, Chai Y, Lu P, Yang N, Chen M, Yang Y, Chen Q, Liu Z. Oral Delivery of Therapeutic Antibodies with a Transmucosal Polymeric Carrier. ACS Nano 2023;17:4373-86. [PMID: 36802527 DOI: 10.1021/acsnano.2c09266] [Reference Citation Analysis]
4 Chu C, Deng Y, Liu H, Wei M, Xu X, Gou J, He H, Yin T, Zhang Y, Tang X. In situ rearranged multifunctional lipid nanoparticles via synergistic potentiation for oral insulin delivery. Int J Pharm 2023;636:122811. [PMID: 36894044 DOI: 10.1016/j.ijpharm.2023.122811] [Reference Citation Analysis]
5 Patil SM, Barji DS, Aziz S, McChesney DA, Bagde S, Muttil P, Kunda NK. Pulmonary delivery of spray-dried Nisin ZP antimicrobial peptide for non-small cell lung cancer (NSCLC) treatment. Int J Pharm 2023;634:122641. [PMID: 36709012 DOI: 10.1016/j.ijpharm.2023.122641] [Reference Citation Analysis]
6 Li A, Su X, Hu S, Wang Y. Efficacy and safety of oral semaglutide in type 2 diabetes mellitus: A systematic review and meta-analysis. Diabetes Res Clin Pract 2023;198:110605. [PMID: 36871874 DOI: 10.1016/j.diabres.2023.110605] [Reference Citation Analysis]
7 Bashir S, Fitaihi R, Abdelhakim HE. Advances in formulation and manufacturing strategies for the delivery of therapeutic proteins and peptides in orally disintegrating dosage forms. Eur J Pharm Sci 2023;182:106374. [PMID: 36623699 DOI: 10.1016/j.ejps.2023.106374] [Reference Citation Analysis]
8 Kulkarni R, Fanse S, Burgess DJ. Mucoadhesive drug delivery systems: a promising noninvasive approach to bioavailability enhancement. Part II: formulation considerations. Expert Opin Drug Deliv 2023;20:413-34. [PMID: 36803264 DOI: 10.1080/17425247.2023.2181332] [Reference Citation Analysis]
9 Yang Y, Zhou R, Wang Y, Zhang Y, Yu J, Gu Z. Recent Advances in Oral and Transdermal Protein Delivery Systems. Angew Chem Int Ed Engl 2023;62:e202214795. [PMID: 36478123 DOI: 10.1002/anie.202214795] [Reference Citation Analysis]
10 Hu K, Huang H, Li H, Wei Y, Yao C. Legume-Derived Bioactive Peptides in Type 2 Diabetes: Opportunities and Challenges. Nutrients 2023;15. [PMID: 36904097 DOI: 10.3390/nu15051096] [Reference Citation Analysis]
11 Xin W, Wang L, Lin J, Wang Y, pan Q, Han Y, Bao Z, Zong S, Cheng Y, Chen X, Zhao L, Li H. Mesoporous silica nanoparticles with chiral pattern topological structure function as “antiskid tires” on the intestinal mucosa to facilitate oral drugs delivery. Asian Journal of Pharmaceutical Sciences 2023. [DOI: 10.1016/j.ajps.2023.100795] [Reference Citation Analysis]
12 Xu Y, Amakye WK, Xiao G, Liu X, Ren J, Wang M. Intestinal absorptivity-increasing effects of sodium N-[8-(2-hydroxybenzoyl)amino]-caprylate on food-derived bioactive peptide. Food Chemistry 2023;401:134059. [DOI: 10.1016/j.foodchem.2022.134059] [Reference Citation Analysis]
13 Luo X, Chen H, Song Y, Qin Z, Xu L, He N, Tan Y, Dessie W. Advancements, challenges and future perspectives on peptide-based drugs: Focus on antimicrobial peptides. Eur J Pharm Sci 2023;181:106363. [PMID: 36529161 DOI: 10.1016/j.ejps.2022.106363] [Reference Citation Analysis]
14 Wu J, Xing L, Zheng Y, Yu Y, Wu R, Liu X, Li L, Huang Y. Disease-specific protein corona formed in pathological intestine enhances the oral absorption of nanoparticles. Acta Pharmaceutica Sinica B 2023. [DOI: 10.1016/j.apsb.2023.02.012] [Reference Citation Analysis]
15 Gong L, Zhao H, Liu Y, Wu H, Liu C, Chang S, Chen L, Jin M, Wang Q, Gao Z, Huang W. Research advances in peptide‒drug conjugates. Acta Pharmaceutica Sinica B 2023. [DOI: 10.1016/j.apsb.2023.02.013] [Reference Citation Analysis]
16 Emami F, Keihan Shokooh M, Mostafavi Yazdi SJ. Recent progress in drying technologies for improving the stability and delivery efficiency of biopharmaceuticals. J Pharm Investig 2023;53:35-57. [PMID: 36568503 DOI: 10.1007/s40005-022-00610-x] [Reference Citation Analysis]
17 Shah P, Basant. Strategies for Formulation and Systemic Delivery of Therapeutic Proteins. Protein-based Therapeutics 2023. [DOI: 10.1007/978-981-19-8249-1_6] [Reference Citation Analysis]
18 Calderón-Colón X, Zhang Y, Tiburzi O, Wang J, Hou S, Raimondi G, Patrone J. Design and characterization of lipid nanocarriers for oral delivery of immunotherapeutic peptides. J Biomed Mater Res A 2022. [PMID: 36585800 DOI: 10.1002/jbm.a.37477] [Reference Citation Analysis]
19 Gadziński P, Froelich A, Jadach B, Wojtyłko M, Tatarek A, Białek A, Krysztofiak J, Gackowski M, Otto F, Osmałek T. Ionotropic Gelation and Chemical Crosslinking as Methods for Fabrication of Modified-Release Gellan Gum-Based Drug Delivery Systems. Pharmaceutics 2022;15. [PMID: 36678736 DOI: 10.3390/pharmaceutics15010108] [Reference Citation Analysis]
20 Saxena T, Sie C, Lin K, Ye D, Saatchi K, Häfeli UO. Potential of Nuclear Imaging Techniques to Study the Oral Delivery of Peptides. Pharmaceutics 2022;14. [PMID: 36559303 DOI: 10.3390/pharmaceutics14122809] [Reference Citation Analysis]
21 Takyo M, Sato Y, Hirata N, Tsuchiya K, Ishida H, Kurohara T, Yanase Y, Ito T, Kanda Y, Yamamoto K, Misawa T, Demizu Y. Oligoarginine-Conjugated Peptide Foldamers Inhibiting Vitamin D Receptor-Mediated Transcription. ACS Omega 2022;7:46573-82. [PMID: 36570290 DOI: 10.1021/acsomega.2c05409] [Reference Citation Analysis]
22 Bolhassani A. Lipid-Based Delivery Systems in Development of Genetic and Subunit Vaccines. Mol Biotechnol 2022;:1-30. [PMID: 36462102 DOI: 10.1007/s12033-022-00624-8] [Reference Citation Analysis]
23 Mbituyimana B, Ma G, Shi Z, Yang G. Polymer-based microneedle composites for enhanced non-transdermal drug delivery. Applied Materials Today 2022;29:101659. [DOI: 10.1016/j.apmt.2022.101659] [Reference Citation Analysis]
24 Anand U, Bandyopadhyay A, Jha NK, Pérez de la Lastra JM, Dey A. Translational aspect in peptide drug discovery and development: An emerging therapeutic candidate. BioFactors 2022. [DOI: 10.1002/biof.1913] [Reference Citation Analysis]
25 Maruyama M, Nishida Y, Tanaka H, Minami T, Ogawara K, Miyake M, Takamura Y, Kakuta H, Higaki K. Analysis of absorption-enhancing mechanisms for combinatorial use of spermine with sodium taurocholate in Caco-2 cells. European Journal of Pharmaceutics and Biopharmaceutics 2022;180:332-343. [DOI: 10.1016/j.ejpb.2022.10.020] [Reference Citation Analysis]
26 Fu M, Mi S, Zhao J, Wang X, Gao J, Sang Y. The interaction mechanism, conformational changes and computational simulation of the interaction between surface layer protein and mannan at different pH levels. Food Chemistry 2022. [DOI: 10.1016/j.foodchem.2022.135021] [Reference Citation Analysis]
27 Brayden DJ. Localised Delivery of Macromolecules to the Large Intestine: Translation to Clinical Trials. BioDrugs 2022. [DOI: 10.1007/s40259-022-00562-6] [Reference Citation Analysis]
28 Aroda VR, Blonde L, Pratley RE. A new era for oral peptides: SNAC and the development of oral semaglutide for the treatment of type 2 diabetes. Rev Endocr Metab Disord 2022;23:979-94. [PMID: 35838946 DOI: 10.1007/s11154-022-09735-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
29 Yuan J, Guo M, Zhao S, Li J, Wang X, Yang J, Jin Z, Song X. Core-shell lipid-polymeric nanoparticles for enhanced oral bioavailability and antihypertensive efficacy of KY5 peptide. Chinese Chemical Letters 2022. [DOI: 10.1016/j.cclet.2022.107943] [Reference Citation Analysis]
30 Phan VHG, Mathiyalagan R, Nguyen MT, Tran TT, Murugesan M, Ho TN, Huong H, Yang DC, Li Y, Thambi T. Ionically cross-linked alginate-chitosan core-shell hydrogel beads for oral delivery of insulin. Int J Biol Macromol 2022;222:262-71. [PMID: 36150568 DOI: 10.1016/j.ijbiomac.2022.09.165] [Reference Citation Analysis]
31 Javan Nikkhah S, Thompson D. Copolyelectrolyte-Based Nanocapsules for Oral Monoclonal Antibody Therapy: A Mesoscale Modeling Survey. Biomacromolecules 2022. [PMID: 35916698 DOI: 10.1021/acs.biomac.2c00699] [Reference Citation Analysis]
32 Vambhurkar G, Amulya E, Sikder A, Shah S, Famta P, Khatri DK, Singh SB, Srivastava S. Nanomedicine based Potentially Transformative Strategies for Colon Targeting of Peptides: State-of-the-art. Colloids and Surfaces B: Biointerfaces 2022. [DOI: 10.1016/j.colsurfb.2022.112816] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Quarta E, Esposti LD, Bettini R, Sonvico F, Catalucci D, Iafisco M, De Luca C, Trevisi G, Colombo P, Rossi A, Buttini F, Colombo G. Dry powder inhalation technology for heart targeting applied to calcium phosphate nanoparticles loaded with active substances. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.103719] [Reference Citation Analysis]
34 Li DF, Yang MF, Xu HM, Zhu MZ, Zhang Y, Tian CM, Nie YQ, Wang JY, Liang YJ, Yao J, Wang LS. Nanoparticles for oral delivery: targeted therapy for inflammatory bowel disease. J Mater Chem B 2022. [PMID: 35876136 DOI: 10.1039/d2tb01190e] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
35 Carter PJ, Rajpal A. Designing antibodies as therapeutics. Cell 2022;185:2789-805. [PMID: 35868279 DOI: 10.1016/j.cell.2022.05.029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Zhang L, Dong Z, Liu W, Wu X, He H, Lu Y, Wu W, Qi J. Novel Pharmaceutical Strategies for Enhancing Skin Penetration of Biomacromolecules. Pharmaceuticals (Basel) 2022;15:877. [PMID: 35890174 DOI: 10.3390/ph15070877] [Reference Citation Analysis]
37 Hong Z, Xie J, Wang X, Dai J, Mao J, Bai Y, Sheng J, Tian Y. Moringa oleifera Lam. Peptide Remodels Intestinal Mucosal Barrier by Inhibiting JAK-STAT Activation and Modulating Gut Microbiota in Colitis. Front Immunol 2022;13:924178. [DOI: 10.3389/fimmu.2022.924178] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Panigrahy SK, Kumar A. Biopolymeric nanocarrier: an auspicious system for oral delivery of insulin. Journal of Biomaterials Science, Polymer Edition 2022. [DOI: 10.1080/09205063.2022.2096527] [Reference Citation Analysis]
39 Huang M, Zhang M, Zhu H, Du X, Wang J. Mucosal vaccine delivery: A focus on the breakthrough of specific barriers. Acta Pharm Sin B 2022. [PMID: 35818435 DOI: 10.1016/j.apsb.2022.07.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
40 Liu H, Zhao X, Bai Y, Xie H, Yang Z, Wang Y, Chen Y, Luo Y, Ma M, Lu W, Ma J, Yang T, Jin B, Ding P. Amphiphilic cationic triblock polymers for p53-mediated triple-negative breast cancer gene therapy. Materials & Design 2022;219:110758. [DOI: 10.1016/j.matdes.2022.110758] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Weißenborn L, Richel E, Hüseman H, Welzer J, Beck S, Schäfer S, Sticht H, Überla K, Eichler J. Smaller, Stronger, More Stable: Peptide Variants of a SARS-CoV-2 Neutralizing Miniprotein. Int J Mol Sci 2022;23:6309. [PMID: 35682988 DOI: 10.3390/ijms23116309] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
42 Lamers C. Overcoming the shortcomings of peptide-based therapeutics. Future Drug Discovery 2022;4. [DOI: 10.4155/fdd-2022-0005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
43 Cheng Y, Wu I, Chen Y, Chu I. Thermo-Sensitive mPEG-PA-PLL Hydrogel for Drug Release of Calcitonin. Gels 2022;8:282. [DOI: 10.3390/gels8050282] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
44 Hu X, Zhang Q, Zhang Q, Ding J, Liu Y, Qin W. An updated review of functional properties, debittering methods, and applications of soybean functional peptides. Crit Rev Food Sci Nutr 2022;:1-16. [PMID: 35482930 DOI: 10.1080/10408398.2022.2062587] [Reference Citation Analysis]
45 Peng S, Song H, Chen Y, Li S, Guan X. Oral Delivery of Food-derived Bioactive Peptides: Challenges and Strategies. Food Reviews International. [DOI: 10.1080/87559129.2022.2062772] [Reference Citation Analysis]
46 Jiang L, Sun Y, Lu A, Wang X, Shi Y. Ionic Liquids: Promising Approach for Oral Drug Delivery. Pharm Res 2022. [PMID: 35449344 DOI: 10.1007/s11095-022-03260-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Galindres DM, Cifuentes D, Tinoco LE, Murillo-acevedo Y, Rodrigo MM, Ribeiro ACF, Esteso MA. A Review of the Application of Resorcinarenes and SBA-15 in Drug Delivery. Processes 2022;10:684. [DOI: 10.3390/pr10040684] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
48 Haddadzadegan S, Dorkoosh F, Bernkop-Schnürch A. Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers. Adv Drug Deliv Rev 2022;182:114097. [PMID: 34999121 DOI: 10.1016/j.addr.2021.114097] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 25.0] [Reference Citation Analysis]
49 Calderón-colón X, Zhang Y, Tiburzi O, Wang J, Raimondi G, Patrone J. Design and Characterization of Lipid Nanocarriers for Oral Delivery of Immunotherapeutic Peptides.. [DOI: 10.1101/2022.01.27.478027] [Reference Citation Analysis]
50 Abdel-Moneim A, Ramadan H. Novel strategies to oral delivery of insulin: Current progress of nanocarriers for diabetes management. Drug Dev Res 2021. [PMID: 34859477 DOI: 10.1002/ddr.21903] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
51 Er S, Laraib U, Arshad R, Sargazi S, Rahdar A, Pandey S, Thakur VK, Díez-Pascual AM. Amino Acids, Peptides, and Proteins: Implications for Nanotechnological Applications in Biosensing and Drug/Gene Delivery. Nanomaterials (Basel) 2021;11:3002. [PMID: 34835766 DOI: 10.3390/nano11113002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
52 Lv Y, He W, Wu W. Editorial of Special Issue of Hot Topic Reviews in Drug Delivery. Acta Pharm Sin B 2021;11:2094-5. [PMID: 34522578 DOI: 10.1016/j.apsb.2021.08.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]